Skip to main content
Premium Trial:

Request an Annual Quote

Ronnie Andrews

Insight Genetics has appointed Ronald (Ronnie) Andrews to its board of directors. Andrews also joined the firm's investor base as part of a new $3 million investment round. Andrews is the former president of the genetic science division of Thermo Fisher Scientific, and he was president of medical sciences for Life Technologies before it was acquired by Thermo Fisher. Andrews has also served as CEO of Clarient until its sale to GE Healthcare and is a founder of The Bethesda Group, which works with companies to commercialize their technologies.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.